Skip to content
Review

An Atlas of Modifiers of Age at Onset in Huntington's Disease.

Sep 2026 · Current Neuropharmacology · Vol 24 · 0 citations
Medicine

TL;DR

This study conducted the first comprehensive Mendelian randomization (MR) analysis of AAO causal determinants in HD, highlighting modifiable biological and lifestyle factors that may underpin future preventive or therapeutic interventions.

Abstract

Background

Huntington's disease (HD) is a fatal neurodegenerative disorder lacking effective treatment. The relationship between modifiable factors and age at onset (AAO) in HD remains controversial and causally unconfirmed. Identifying causal modifiers of AAO is crucial for delaying onset and disease prevention.

Method

This study conducted the first comprehensive Mendelian randomization (MR) analysis of AAO causal determinants in HD. We reviewed previous observational and MR studies and identified 36 potential modifiers, of which 26 with available genetic instrument were analyzed. Summary statistics for residual AAO were obtained from the largest GWAS by the GeM-HD Consortium. The inverse-variance weighted method served as the primary analysis, with multiple sensitivity tests for robustness. Multivariable MR evaluated independent effects of exposures.

Results

Univariable MR identified 14 modifiers causally associated with AAO. Six previously reported factors were replicated, including telomere length, leisure screen time, coffee consumption and metabolism, smoking behaviors, diastolic blood pressure, and target effect of calcium channel blockers (CCBs). Eight novel modifiers were discovered, including education, economic status, adiposity distribution, appendicular lean mass, overall effects of CCBs, triglycerides, and target effect of lipid-lowering drugs and overall effects of statins. Multivariable MR confirmed eight independent factors: education, leisure screen time, coffee consumption, smoking behaviors, visceral adiposity, overall effects of CCBs, triglycerides, and overall effects of statin use. All associations were consistent across sensitivity analyses.

Conclusions

These findings provide the most comprehensive causal landscape of AAO modifiers in HD to date, highlighting modifiable biological and lifestyle factors that may underpin future preventive or therapeutic interventions.

View source

Similar papers

Open access Sep 2026

Identification of Plasma Protein Biomarkers for Early-Onset Stroke through Mendelian Randomization

This large-scale proteome-wide Mendelian randomization study identified multiple plasma proteins with likely causal roles in EOS, implicating coagulation, platelet activation, extracellular matrix remodeling, and immune pathways in disease etiology.

A. Huynh, B. Gaynor, J. W. Cole et al. · 0 citations
Sep 2026

Exposure-wide association study-assisted identification of modifiable factors for depression prevention.

Depression is a leading cause of disability worldwide, yet evidence on modifiable factors remains limited and fragmented. Using UK Biobank data, we comprehensively evaluated 218 modifiable factors across eight predefined domains and integrated polygenic risk scores to inform prevention. Among 290,278 participants (mean...

Jian-Hui Guo, Ya-Wen Zheng, Fei-Fei Si et al. · 0 citations
Open access Aug 2026

Causal effects of diabetes and alcohol intake on Dupuytren's disease: a two-sample Mendelian randomization study in UK Biobank and FinnGen.

This MR study supported diabetes liability and higher alcohol intake as causal risk factors for DD, whereas genetically proxied obesity and smoking traits showed no clear causal effects, suggesting that better glycemic management and lower alcohol exposure may help reduce the risk of DD.

Heng Tian, Ling Hong, Wenlai Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.